Pharma

Wockhardt jumps on US FDA nod for generic drug

 

dIgitalhealth

Wockhardt and Sun Pharmaceutical have received final approval from the United States Food and Drug Administration (USFDA) to market generic versions of Nicardipine, the hypertension drug.

Following which, share price of Wockhardt jumped to a high of Rs 185, and is now up 1.5% at Rs 183. The counter has seen trades of around 36,600 shares so far on the BSE.

Meanwhile, Sun Pharma is trading flat at Rs 1,440. Around 5,880 shares have changed hands at the counter on the BSE.

dIgitalhealth

Follow and connect with us on Facebook, Twitter, LinkedIn, Elets video

Eletsonline News

Follow us on


Most Popular

SUBSCRIBE OUR NEWSLETTER
200000+ Subscribers read it every day.
Subscribe Newsletter
To Top